Title |
Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation
|
---|---|
Published in |
Frontiers in immunology, November 2015
|
DOI | 10.3389/fimmu.2015.00585 |
Pubmed ID | |
Authors |
Talia H. Swartz, George R. Dubyak, Benjamin K. Chen |
Abstract |
Human immunodeficiency virus type 1 (HIV-1) causes a chronic infection that afflicts more than 30 million individuals worldwide. While the infection can be suppressed with potent antiretroviral therapies, individuals infected with HIV-1 have elevated levels of inflammation as indicated by increased T cell activation, soluble biomarkers, and associated morbidity and mortality. A single mechanism linking HIV-1 pathogenesis to this inflammation has yet to be identified. Purinergic receptors are known to mediate inflammation and have been shown to be required for HIV-1 infection at the level of HIV-1 membrane fusion. Here, we review the literature on the role of purinergic receptors in HIV-1 infection and associated inflammation and describe a role for these receptors as potential therapeutic targets. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 21% |
Student > Ph. D. Student | 6 | 18% |
Student > Bachelor | 3 | 9% |
Student > Doctoral Student | 3 | 9% |
Professor > Associate Professor | 3 | 9% |
Other | 7 | 21% |
Unknown | 5 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 12 | 35% |
Medicine and Dentistry | 6 | 18% |
Agricultural and Biological Sciences | 4 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
Biochemistry, Genetics and Molecular Biology | 2 | 6% |
Other | 1 | 3% |
Unknown | 6 | 18% |